SMMT logo

Summit Therapeutics (SMMT)

Profile

Full Name

Summit Therapeutics Inc.

Ticker Symbol

SMMT

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

March 5, 2015

Indexes

Not included

Website

http://www.summittxinc.com

Employees

159

Key Details

Price

$23.50(-10.08%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$0.31(+68.69% YoY)

PE ratio

-

Next earnings date

May 1, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$23.50
SMMT price is $23.50

30-Day Relative Volume

1.80
SMMT 30-day relative volume is 1.80

Price Performance

Price Today change

-10.08%
SMMT price is down -10.08% today

Price YTD change

+31.66%
SMMT price is up +31.66% since January 1st

Price 1-year change

+542.82%
SMMT price is up +542.82% year-on-year

Price 3-year change

+982.72%
SMMT price is up +982.72% over the past 3 years

Price Range

Price All-time high

$33.89
SMMT price is currently -30.67% below its historical high of $33.89

Price 3-year low

$0.66
SMMT price is currently +3459.85% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$17.33B
SMMT market capitalization is $17.33 billion

Market cap 3-year change

+8039.83%
SMMT market capitalization is up +8039.83% over the past 3 years

Market cap All-time high

$24.29B
SMMT market capitalization is currently -28.64% below its historical high of $24.29 billion

Market cap sector rank

95.23%
SMMT market capitalization is higher than 95.23% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+5.09%
SMMT shares outstanding is up +5.09% year-on-year

Shares Outstanding 3-Year Change

+651.8%
SMMT shares outstanding is up +651.8% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.01
SMMT beta is 1.01

200-day SMA

$17.76
SMMT price is currently +32.28% above its 200-day simple moving average

50-day SMA

$19.90
SMMT price is currently +18.04% above its 50-day simple moving average

RSI

69.28
SMMT 14-day relative strength index is 69.28

Volume

1.80
SMMT 30-day relative volume is 1.80

ATR

$2.31
SMMT average true range is $2.31

10-day Historical Volatility

139.96%
SMMT 10-day historical volatility is 139.96%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
SMMT annual revenue value is unknown

Revenue Analysts estimate

-
SMMT annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
SMMT annual revenue 1-year change is unknown

Revenue Sector rank

-
SMMT annual revenue is unknown

EPS

EPS

-$0.31
SMMT annual earnings per share is -$0.31

EPS Analysts estimate

-$0.32
SMMT annual earnings per share is currently -2.82% lower than the consensus analysts' forecast

EPS 1-year change

+68.69%
SMMT annual earnings per share is up +68.69% year-on-year

EPS Sector rank

74.36%
SMMT annual earnings per share is higher than 74.36% of companies in Healthcare sector

Profit

Gross profit

-
SMMT annual gross profit value is unknown

Gross margin

-
SMMT annual gross profit margin value is unknown

Operating profit

-$225.97M
SMMT annual operating income is -$225.97 million

Operating margin

-
SMMT annual operating profit margin value is unknown

Net income

-$221.31M
SMMT annual net profit is -$221.31 million

Net margin

-
SMMT annual net profit margin value is unknown

Expenses

Total expenses

$225.97M
SMMT annual total expenses is $225.97 million

Operating expenses

$225.97M
SMMT annual total operating expenses is $225.97 million

Cost of goods sold

-
SMMT annual cost of goods sold value is unknown

Selling, general & administrative expenses

$60.50M
SMMT annual SGA is $60.50 million

Depreciation and amortization

$89.00K
SMMT annual depreciation & amortization is $89.00 thousand

Interest expense

$8.69M
SMMT annual interest expense is $8.69 million

Income tax

-
SMMT annual income tax value is unknown

EBIT & EBITDA

EBIT

-$212.60M
SMMT annual earnings before interest & taxes is -$212.60 million

EBITDA

-$212.51M
SMMT annual EBITDA is -$212.51 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$435.56M
SMMT annual total assets is $435.56 million

Non current assets

$11.81M
SMMT annual long term assets is $11.81 million

Current assets

$423.75M
SMMT annual total current assets is $423.75 million

Cash and cash equivalents

$104.86M
SMMT annual cash & cash equivalents is $104.86 million

Accounts receivable

-
SMMT annual accounts receivable value is unknown

Inventory

-
SMMT annual inventory value is unknown

Liabilities

Total liabilities

$46.81M
SMMT annual total liabilities is $46.81 million

Long term liabilities

$5.08M
SMMT annual total long term liabilities is $5.08 million

Current liabilities

$41.73M
SMMT annual total current liabilities is $41.73 million

Accounts payable

$4.64M
SMMT annual accounts payable is $4.64 million

Debt

Total debt

$7.22M
SMMT annual total debt is $7.22 million

Total debt 1-year change

-93.2%
SMMT annual total debt is down -93.2% year-on-year

Long term debt

$3.45M
SMMT annual long term debt is $3.45 million

Short term debt

$3.77M
SMMT annual short term debt is $3.77 million

Equity & Capital

Shareholders equity

$388.75M
SMMT annual stockholders equity is $388.75 million

Book value

$388.75M
SMMT annual book value is $388.75 million

Retained earnings

-$1.21B
SMMT annual retained earnings is -$1.21 billion

Working capital

$382.02M
SMMT annual working capital is $382.02 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$142.11M
SMMT annual cash flow from operations is -$142.11 million

Cash from operations 1-year change

-85.13%
SMMT annual cash flow from operations is down -85.13% year-on-year

Cash from investing

-$205.34M
SMMT annual cash flow from investing activities is -$205.34 million

Cash from investing 1-year change

+65.06%
SMMT annual cash flow from investing activities is up +65.06% year-on-year

Cash from financing

$381.23M
SMMT annual cash flow from financing activities is $381.23 million

Cash from financing 1-year change

+340.66%
SMMT annual cash flow from financing activities is up +340.66% year-on-year

CAPEX

CAPEX

-
SMMT annual capital expenditures value is unknown

CAPEX 1-year change

-
SMMT annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$142.25M
SMMT annual free cash flow is -$142.25 million

Free cash flow 1-year change

-85%
SMMT annual free cash flow is down -85% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
SMMT annual gross profit margin value is unknown

Operating margin

-
SMMT annual operating profit margin value is unknown

Net margin

-
SMMT annual net profit margin value is unknown

ROA & ROE

ROA

-50.81%
SMMT annual return on assets is -50.81%

ROE

-56.93%
SMMT annual return on equity is -56.93%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
SMMT price to earnings ratio value is unknown

PE ratio Sector rank

-
SMMT price to earnings ratio is unknown

PB Ratio

PB ratio

44.58
SMMT price to book ratio is 44.58

PB ratio Sector rank

98.52%
SMMT price to book ratio is higher than 98.52% of companies in Healthcare sector

PS Ratio

PS ratio

-
SMMT price to sales ratio value is unknown

PS ratio Sector rank

-
SMMT price to sales ratio is unknown

Enterprise value

Enterprise value

$17.23B
SMMT enterprise value is $17.23 billion

Enterprise value Sector rank

94.38%
SMMT enterprise value is higher than 94.38% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-81.10
SMMT EV/EBITDA is -81.10

EV/EBITDA Sector rank

1.65%
SMMT EV/EBITDA is higher than 1.65% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

10.15
SMMT annual current ratio is 10.15

Quick ratio

-
SMMT annual quick ratio value is unknown

Leverage

Debt to equity

0.02
SMMT annual debt to equity ratio is 0.02

Interest coverage ratio

-24.48
SMMT annual interest coverage ratio is -24.48

Risk & Stability

Piotroski F-Score

-
SMMT piotroski f-score value is unknown

Altman Z-Score

-
SMMT altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Mar 26, 25 Citigroup
Buy
Mar 21, 25 Cantor Fitzgerald
Overweight
Mar 12, 25 Evercore ISI Group
Outperform
Feb 28, 25 Goldman Sachs
Buy
Feb 25, 25 HC Wainwright & Co.
Buy
Feb 25, 25 Citizens Capital Markets
Market Outperform
Jan 21, 25 HC Wainwright & Co.
Buy
Jan 8, 25 Truist Securities
Buy
Dec 11, 24 Wells Fargo
Overweight
Dec 6, 24 Jefferies
Buy

Institutional Ownership

Similar stocks

MOH logo
Molina Healthcare (MOH)
LH logo
Laboratory Corporation of America Holdings (LH)
WAT logo
Waters (WAT)
DGX logo
Quest Diagnostics Incorporated (DGX)
NTRA logo
Natera (NTRA)
ZBH logo
Zimmer Biomet Holdings (ZBH)
PODD logo
Insulet (PODD)
BIIB logo
Biogen (BIIB)
PHG logo
Koninklijke Philips NV (PHG)
  • What is the ticker symbol for Summit Therapeutics?
  • Does Summit Therapeutics pay dividends?
  • What sector is Summit Therapeutics in?
  • What industry is Summit Therapeutics in?
  • What country is Summit Therapeutics based in?
  • When did Summit Therapeutics go public?
  • Is Summit Therapeutics in the S&P 500?
  • Is Summit Therapeutics in the NASDAQ 100?
  • Is Summit Therapeutics in the Dow Jones?
  • When was Summit Therapeutics's last earnings report?
  • When does Summit Therapeutics report earnings?
  • Should I buy Summit Therapeutics stock now?

What is the ticker symbol for Summit Therapeutics?

The ticker symbol for Summit Therapeutics is NASDAQ:SMMT

Does Summit Therapeutics pay dividends?

No, Summit Therapeutics does not pay dividends

What sector is Summit Therapeutics in?

Summit Therapeutics is in the Healthcare sector

What industry is Summit Therapeutics in?

Summit Therapeutics is in the Biotechnology industry

What country is Summit Therapeutics based in?

Summit Therapeutics is headquartered in United States

When did Summit Therapeutics go public?

Summit Therapeutics's initial public offering (IPO) was on March 5, 2015

Is Summit Therapeutics in the S&P 500?

No, Summit Therapeutics is not included in the S&P 500 index

Is Summit Therapeutics in the NASDAQ 100?

No, Summit Therapeutics is not included in the NASDAQ 100 index

Is Summit Therapeutics in the Dow Jones?

No, Summit Therapeutics is not included in the Dow Jones index

When was Summit Therapeutics's last earnings report?

Summit Therapeutics's most recent earnings report was on Feb 24, 2025

When does Summit Therapeutics report earnings?

The next expected earnings date for Summit Therapeutics is May 1, 2025

Should I buy Summit Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page